JOY ELLIS-GEORGE: Open Payments
NPI 1124586623 · UPPER MARLBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 15 payments from 7 companies in 2025. Trend: 2023 $148 · 2024 $484 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 4 | $84 |
| Alkermes, Inc. | 4 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $69 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
Products named: ARISTADA, INVEGA SUSTENNA, REXULTI, Qelbree, INGREZZA, VRAYLAR, UZEDY, ABILIFY ASIMTUFII.
Industry payments across MD — which companies pay providers there.
